-
Alcamí A, Smith GL, 1992: A soluble receptor for interleukin-1 beta encoded by vaccinia virus: a novel mechanism of virus modulation of the host response to infection[J]. Cell, 71, 153-167. doi: 10.1016/0092-8674(92)90274-G
-
Antoine G, Scheiflinger F, Dorner F, Falkner FG, 1998: The complete genomic sequence of the modified vaccinia Ankara strain: comparison with other orthopoxviruses[J]. Virology, 244, 365-396. doi: 10.1006/viro.1998.9123
-
Antoine G, Scheiflinger F, Dorner F, Falkner FG, 2006: Corrigendum to pThe complete genomic sequence of the modified vaccinia Ankara (MVA) strain: comparison with other orthopoxvirusesq[Virology 244 (1998) 365-396][J]. Virology, 350, 501-502. doi: 10.1016/j.virol.2006.04.025
-
Bertholet C, Drillien R, Wittek R, 1985: One hundred base pairs of 5¤ flanking sequence of a vaccinia virus late gene are sufficient to temporally regulate late transcription[J]. Proc Natl Acad Sci USA, 82, 2096-2100. doi: 10.1073/pnas.82.7.2096
-
Blanchard TJ, Alcami A, Andrea P, Smith GL, 1998: Modified vaccinia virus Ankara undergoes limited replication in human cells and lacks several immunomodulatory proteins: implications for use as a human vaccine[J]. J Gen Virol, 79, 1159-1167. doi: 10.1099/0022-1317-79-5-1159
-
Blasco R, Moss B, 1991: Extracellular vaccinia virus formation and cell-to-cell virus transmission are prevented by deletion of the gene encoding the 37, 000-Dalton outer envelope protein[J]. J Virol, 65, 5910-5920. doi: 10.1128/JVI.65.11.5910-5920.1991
-
Blasco R, Sisler JR, Moss B, 1993: Dissociation of progeny vaccinia virus from the cell membrane is regulated by a viral envelope glycoprotein: effect of a point mutation in the lectin homology domain of the A34R gene[J]. J Virol, 67, 3319-3325. doi: 10.1128/JVI.67.6.3319-3325.1993
-
Byrd CM, Bolken TC, Hruby DE, 2002: The vaccinia virus I7L gene product is the core protein proteinase[J]. J Virol, 76, 8973-8976. doi: 10.1128/JVI.76.17.8973-8976.2002
-
Carroll MW, Moss B, 1997: Host range and cytopathogenicity of the highly attenuated MVA strain of vaccinia virus: propagation and generation of recombinant viruses in a nonhuman mammalian cell line[J]. Virology, 238, 198-211. doi: 10.1006/viro.1997.8845
-
Cebere I, Dorrell L, McShane H, Simmons A, McCormack S, Schmidt C, Smith C, Brooks M, Roberts JE, Darwin SC, Fast PE, Conlon C, Rowland-Jones S, McMichael AJ, Hanke T, 2006: Phase Ⅰ clinical trial safety of DNA- and modified virus Ankara-vectored human immunodeficiency virus type 1 (HIV-1) vaccines administered alone and in a prime-boost regime to healthy HIV-1-uninfected volunteers[J]. Vaccine, 24, 417-425. doi: 10.1016/j.vaccine.2005.08.041
-
Chakrabarti S, Sisler JR, Moss B, 1997: Compact, synthetic, vaccinia virus early/late promoter for protein expression[J]. Biotechniques, 23, 1094-1097. doi: 10.2144/97236st07
-
Chung CS, Chen CH, Ho MY, Huang CY, Liao CL, Chang W, 2006: Vaccinia virus proteome: identification of proteins in vaccinia virus intracellular mature virion particles[J]. J Virol, 80, 2127-2140. doi: 10.1128/JVI.80.5.2127-2140.2006
-
Cottingham MG, Carroll MW, 2013: Recombinant MVA vaccines: dispelling the myths[J]. Vaccine, 31, 4247-4251. doi: 10.1016/j.vaccine.2013.03.021
-
Cyrklaff M, Linaroudis A, Boicu M, Chlanda P, Baumeister W, Griffiths G, Krijnse-Locker J, 2007: Whole cell cryo-electron tomography reveals distinct disassembly intermediates of vaccinia virus[J]. PLoS ONE, 2, e420-. doi: 10.1371/journal.pone.0000420
-
Dobson BM, Tscharke DC, 2015: Redundancy complicates the definition of essential genes for vaccinia virus[J]. J Gen Virol, 96, 3326-3337. doi: 10.1099/jgv.0.000266
-
Drexler I, Heller K, Wahren B, Erfle V, Sutter G, 1998: Highly attenuated modified vaccinia virus Ankara replicates in baby hamster kidney cells, a potential host for virus propagation, but not in various human transformed and primary cells[J]. J Gen Virol, 79, 347-352. doi: 10.1099/0022-1317-79-2-347
-
Drillien R, Spehner D, Hanau D, 2004: Modified vaccinia virus Ankara induces moderate activation of human dendritic cells[J]. J Gen Virol, 85, 2167-2175. doi: 10.1099/vir.0.79998-0
-
Elde NC, Child SJ, Eickbush MT, Kitzman JO, Rogers KS, Shendure J, Geballe AP, Malik HS, 2012: Poxviruses deploy genomic accordions to adapt rapidly against host antiviral defenses[J]. Cell, 150, 831-841. doi: 10.1016/j.cell.2012.05.049
-
Engelstad M, Smith GL, 1993: The vaccinia virus 42-kDa envelope protein is required for the envelopment and egress of extracellular virus and for virus virulence[J]. Virology, 194, 627-637. doi: 10.1006/viro.1993.1302
-
Falivene J, Del Médico Zajac MP, Pascutti MF, Rodríguez AM, Maeto C, Perdiguero B, Gómez CE, Esteban M, Calamante G, Gherardi MM, 2012: Improving the MVA vaccine potential by deleting the viral gene coding for the IL-18 binding protein[J]. PLoS ONE, 7, e32220-. doi: 10.1371/journal.pone.0032220
-
Folegatti PM, Bellamy D, Flaxman A, Mair C, Ellis C, Ramon RL, Ramos Lopez F, Mitton C, Baker M, Poulton I, Lawrie A, Roberts R, Minassian A, Ewer KJ, Evans TG, Hill AVS, Gilbert SC, 2019: Safety and immunogenicity of the heterosubtypic influenza A vaccine MVA-NP+M1 manufactured on the AGE1.CR.pIX avian cell line[J]. Vaccines, , -. doi: 10.3390/vaccines7010033
-
Gallego-Gómez JC, Risco C, Rodríguez D, Cabezas P, Guerra S, Carrascosa JL, Esteban M, 2003: Differences in virus-induced cell morphology and in virus maturation between MVA and other strains (WR, Ankara, and NYCBH) of vaccinia virus in infected human cells[J]. J Virol, 77, 10606-10622. doi: 10.1128/JVI.77.19.10606-10622.2003
-
Grimley PM, Rosenblum EN, Mims SJ, Moss B, 1970: Interruption by Rifampin of an early stage in vaccinia virus morphogenesis: accumulation of membranes which are precursors of virus envelopes[J]. J Virol, 6, 519-533. doi: 10.1128/JVI.6.4.519-533.1970
-
Heljasvaara R, Rodríguez D, Risco C, Carrascosa JL, Esteban M, Rodríguez JR, 2001: The major core protein P4a (A10L gene) of vaccinia virus is essential for correct assembly of viral DNA into the nucleoprotein complex to form immature viral particles[J]. J Virol, 75, 5778-5795. doi: 10.1128/JVI.75.13.5778-5795.2001
-
Herbert MH, Squire CJ, Mercer AA, 2015: Poxviral ankyrin proteins[J]. Viruses, 7, 709-738. doi: 10.3390/v7020709
-
Husain M, Weisberg AS, Moss B, 2006: Existence of an operative pathway from the endoplasmic reticulum to the immature poxvirus membrane[J]. Proc Natl Acad Sci USA, 103, 19506-19511. doi: 10.1073/pnas.0609406103
-
Husain M, Weisberg AS, Moss B, 2007: Resistance of a vaccinia virus A34R deletion mutant to spontaneous rupture of the outer membrane of progeny virions on the surface of infected cells[J]. Virology, 366, 424-432. doi: 10.1016/j.virol.2007.05.015
-
Jordan I, Horn D, Oehmke S, Leendertz FH, Sandig V, 2009a: Cell lines from the Egyptian fruit bat are permissive for modified vaccinia Ankara[J]. Virus Res, 145, 54-62. doi: 10.1016/j.virusres.2009.06.007
-
Jordan I, Vos A, Beilfuss S, Neubert A, Breul S, Sandig V, 2009b: An avian cell line designed for production of highly attenuated viruses[J]. Vaccine, 27, 748-756. doi: 10.1016/j.vaccine.2008.11.066
-
Jordan I, Northoff S, Thiele M, Hartmann S, Horn D, Höwing K, Bernhardt H, Oehmke S, von Horsten H, Rebeski D, Hinrichsen L, Zelnik V, Mueller W, Sandig V, 2011: A chemically defined production process for highly attenuated poxviruses[J]. Biol J Int Assoc Biol Stand, 39, 50-58. doi: 10.1016/j.biologicals.2010.11.005
-
Jordan I, Horn D, John K, Sandig V, 2013a: A genotype of modified vaccinia Ankara (MVA) that facilitates replication in suspension cultures in chemically defined medium[J]. Viruses, 5, 321-339. doi: 10.3390/v5010321
-
Jordan I, Lohr V, Genzel Y, Reichl U, Sandig V, 2013b: Elements in the development of a production process for modified vaccinia virus Ankara[J]. Microorganisms, 1, 100-121. doi: 10.3390/microorganisms1010100
-
Kato SEM, Strahl AL, Moussatche N, Condit RC, 2004: Temperature-sensitive mutants in the vaccinia virus 4b virion structural protein assemble malformed, transcriptionally inactive intracellular mature virions[J]. Virology, 330, 127-146. doi: 10.1016/j.virol.2004.08.038
-
Katz E, Wolffe E, Moss B, 2002: Identification of second-site mutations that enhance release and spread of vaccinia virus[J]. J Virol, 76, 11637-11644. doi: 10.1128/JVI.76.22.11637-11644.2002
-
Kluczyk A, Siemion IZ, Szewczuk Z, Wieczorek Z, 2002: The immunosuppressive activity of peptide fragments of vaccinia virus C10L protein and a hypothesis on the role of this protein in the viral invasion[J]. Peptides, 23, 823-834. doi: 10.1016/S0196-9781(02)00006-2
-
Kremer M, Volz A, Kreijtz JHCM, Fux R, Lehmann MH, Sutter G, 2012: Easy and efficient protocols for working with recombinant vaccinia virus MVA[J]. Methods Mol Biol Clifton NJ, 890, 59-92. doi: 10.1007/978-1-61779-876-4_4
-
Liu L, Chavan R, Feinberg MB, 2008: Dendritic cells are preferentially targeted among hematolymphocytes by modified vaccinia virus Ankara and play a key role in the induction of virus-specific T cell responses in vivo[J]. BMC Immunol, 9, 15-. doi: 10.1186/1471-2172-9-15
-
Liu B, Panda D, Mendez-Rios JD, Ganesan S, Wyatt LS, Moss B, 2018: Identification of poxvirus genome uncoating and DNA replication factors with mutually redundant roles[J]. J Virol, , -. doi: 10.1128/JVI.02152-17
-
Martin S, Harris DT, Shisler J, 2012: The C11R gene, which encodes the vaccinia virus growth factor, is partially responsible for MVA-induced NF-NJB and ERK2 activation[J]. J Virol, 86, 9629-9639. doi: 10.1128/JVI.06279-11
-
Mayr A, Munz E, 1964: Changes in the vaccinia virus through continuing passages in chick embryo fibroblast cultures[J]. Zentralblatt Für Bakteriol Parasitenkd Infekt Hyg 1 Abt Med-Hyg Bakteriol Virusforsch Parasitol Orig, 195, 24-35.
-
McShane H, Behboudi S, Goonetilleke N, Brookes R, Hill AVS, 2002: Protective immunity against Mycobacterium tuberculosis induced by dendritic cells pulsed with both CD8(+)- and CD4(+)-T-cell epitopes from antigen 85A[J]. Infect Immun, 70, 1623-1626. doi: 10.1128/IAI.70.3.1623-1626.2002
-
Meiser A, Boulanger D, Sutter G, Krijnse Locker J, 2003: Comparison of virus production in chicken embryo fibroblasts infected with the WR, IHD-J and MVA strains of vaccinia virus: IHD-J is most efficient in trans-Golgi network wrapping and extracellular enveloped virus release[J]. J Gen Virol, 84, 1383-1392. doi: 10.1099/vir.0.19016-0
-
Meisinger-Henschel C, Schmidt M, Lukassen S, Linke B, Krause L, Konietzny S, Goesmann A, Howley P, Chaplin P, Suter M, Hausmann J, 2007: Genomic sequence of chorioallantois vaccinia virus Ankara, the ancestor of modified vaccinia virus Ankara[J]. J Gen Virol, 88, 3249-3259. doi: 10.1099/vir.0.83156-0
-
Mercer J, Snijder B, Sacher R, Burkard C, Bleck CKE, Stahlberg H, Pelkmans L, Helenius A, 2012: RNAi screening reveals proteasome- and Cullin3-dependent stages in vaccinia virus infection[J]. Cell Rep, 2, 1036-1047. doi: 10.1016/j.celrep.2012.09.003
-
Meyer H, Sutter G, Mayr A, 1991: Mapping of deletions in the genome of the highly attenuated vaccinia virus MVA and their influence on virulence[J]. J Gen Virol, 72, 1031-1038. doi: 10.1099/0022-1317-72-5-1031
-
Milligan ID, Gibani MM, Sewell R, Clutterbuck EA, Campbell D, Plested E, Nuthall E, Voysey M, Silva-Reyes L, McElrath MJ, De Rosa SC, Frahm N, Cohen KW, Shukarev G, Orzabal N, van Duijnhoven W, Truyers C, Bachmayer N, Splinter D, Samy N, Pau MG, Schuitemaker H, Luhn K, Callendret B, Van Hoof J, Douoguih M, Ewer K, Angus B, Pollard AJ, Snape MD, 2016: Safety and immunogenicity of novel adenovirus type 26- and modified vaccinia Ankara-vectored Ebola vaccines: a randomized clinical trial[J]. JAMA, 315, 1610-1623. doi: 10.1001/jama.2016.4218
-
Mohamed MR, McFadden G, 2009: NFkB inhibitors: strategies from poxviruses[J]. Cell Cycle Georget Tex, 8, 3125-3132. doi: 10.4161/cc.8.19.9683
-
Monticelli SR, Earley AK, Tate J, Ward BM, 2019: The ectodomain of the vaccinia virus glycoprotein A34 is required for cell binding by extracellular virions and contains a large region capable of interaction with glycoprotein B5[J]. J Virol, , -. doi: 10.1128/JVI.01343-18
-
Moss B, 2012: Poxvirus cell entry: how many proteins does it take?[J]. Viruses, 4, 688-707. doi: 10.3390/v4050688
-
Moss B, Winters E, Cooper N, 1981: Instability and reiteration of DNA sequences within the vaccinia virus genome[J]. Proc Natl Acad Sci USA, 78, 1614-1618. doi: 10.1073/pnas.78.3.1614
-
Oie KL, Pickup DJ, 2001: Cowpox virus and other members of the orthopoxvirus genus interfere with the regulation of NF-kappaB activation[J]. Virology, 288, 175-187. doi: 10.1006/viro.2001.1090
-
Olson AT, Rico AB, Wang Z, Delhon G, Wiebe MS, 2017: Deletion of the vaccinia virus B1 kinase reveals essential functions of this enzyme complemented partly by the homologous cellular kinase VRK2[J]. J Virol, , -. doi: 10.1128/JVI.00635-17
-
Olson AT, Wang Z, Rico AB, Wiebe MS, 2019: A poxvirus pseudokinase represses viral DNA replication via a pathway antagonized by its paralog kinase[J]. PLoS Pathog, 15, e1007608-. doi: 10.1371/journal.ppat.1007608
-
Paez E, Dallo S, Esteban M, 1985: Generation of a dominant 8-MDa deletion at the left terminus of vaccinia virus DNA[J]. Proc Natl Acad Sci USA, 82, 3365-3369. doi: 10.1073/pnas.82.10.3365
-
Pickup DJ, Bastia D, Stone HO, Joklik WK, 1982: Sequence of terminal regions of cowpox virus DNA: arrangement of repeated and unique sequence elements[J]. Proc Natl Acad Sci USA, 79, 7112-7116. doi: 10.1073/pnas.79.23.7112
-
Portugal R, Coelho J, Höper D, Little NS, Smithson C, Upton C, Martins C, Leitão A, Keil GM, 2015: Related strains of African swine fever virus with different virulence: genome comparison and analysis[J]. J Gen Virol, 96, 408-419. doi: 10.1099/vir.0.070508-0
-
Qin L, Upton C, Hazes B, Evans DH, 2011: Genomic analysis of the vaccinia virus strain variants found in Dryvax vaccine[J]. J Virol, 85, 13049-13060. doi: 10.1128/JVI.05779-11
-
Resch W, Moss B, 2005: The conserved poxvirus L3 virion protein is required for transcription of vaccinia virus early genes[J]. J Virol, 79, 14719-14729. doi: 10.1128/JVI.79.23.14719-14729.2005
-
Roberts KL, Smith GL, 2008: Vaccinia virus morphogenesis and dissemination[J]. Trends Microbiol, 16, 472-479. doi: 10.1016/j.tim.2008.07.009
-
Santoro MG, Rossi A, Amici C, 2003: NF-kappaB and virus infection: who controls whom[J]. EMBO J, 22, 2552-2560. doi: 10.1093/emboj/cdg267
-
Shisler JL, Jin XL, 2004: The vaccinia virus K1L gene product inhibits host NF-kappaB activation by preventing IkappaBalpha degradation[J]. J Virol, 78, 3553-3560. doi: 10.1128/JVI.78.7.3553-3560.2004
-
Smith VP, Bryant NA, Alcamí A, 2000: Ectromelia, vaccinia and cowpox viruses encode secreted interleukin-18-binding proteins[J]. J Gen Virol, 81, 1223-1230. doi: 10.1099/0022-1317-81-5-1223
-
Sperling KM, Schwantes A, Schnierle BS, Sutter G, 2008: The highly conserved orthopoxvirus 68 k ankyrin-like protein is part of a cellular SCF ubiquitin ligase complex[J]. Virology, 374, 234-239. doi: 10.1016/j.virol.2008.02.018
-
Staib C, Kisling S, Erfle V, Sutter G, 2005: Inactivation of the viral interleukin 1beta receptor improves CD8 + T-cell memory responses elicited upon immunization with modified vaccinia virus Ankara[J]. J Gen Virol, 86, 1997-2006. doi: 10.1099/vir.0.80646-0
-
Suter M, Meisinger-Henschel C, Tzatzaris M, Hülsemann V, Lukassen S, Wulff NH, Hausmann J, Howley P, Chaplin P, 2009: Modified vaccinia Ankara strains with identical coding sequences actually represent complex mixtures of viruses that determine the biological properties of each strain[J]. Vaccine, 27, 7442-7450. doi: 10.1016/j.vaccine.2009.05.095
-
Sutter G, Moss B, 1992: Nonreplicating vaccinia vector efficiently expresses recombinant genes[J]. Proc Natl Acad Sci USA, 89, 10847-10851. doi: 10.1073/pnas.89.22.10847
-
Sutter G, Wyatt LS, Foley PL, Bennink JR, Moss B, 1994: A recombinant vector derived from the host range-restricted and highly attenuated MVA strain of vaccinia virus stimulates protective immunity in mice to influenza virus[J]. Vaccine, 12, 1032-1040. doi: 10.1016/0264-410X(94)90341-7
-
Tapia F, Jordan I, Genzel Y, Reichl U, 2017: Efficient and stable production of modified vaccinia Ankara virus in two-stage semi-continuous and in continuous stirred tank cultivation systems[J]. PLoS ONE, 12, e0182553-. doi: 10.1371/journal.pone.0182553
-
Upton C, Slack S, Hunter AL, Ehlers A, Roper RL, 2003: Poxvirus orthologous clusters: toward defining the minimum essential poxvirus genome[J]. J Virol, 77, 7590-7600. doi: 10.1128/JVI.77.13.7590-7600.2003
-
Vázquez-Ramírez D, Genzel Y, Jordan I, Sandig V, Reichl U, 2018: High-cell-density cultivations to increase MVA virus production[J]. Vaccine, 36, 3124-3133. doi: 10.1016/j.vaccine.2017.10.112
-
Venkatraman N, Ndiaye BP, Bowyer G, Wade D, Sridhar S, Wright D, Powlson J, Ndiaye I, Dièye S, Thompson C, Bakhoum M, Morter R, Capone S, Sorbo MD, Jamieson S, Rampling T, Datoo M, Roberts R, Poulton I, Griffiths O, Ballou WR, Roman F, Lewis DJM, Lawrie A, Imoukhuede E, Gilbert SC, Dieye TN, Ewer KJ, Mboup S, Hill AVS, 2019: Safety and immunogenicity of a heterologous prime-boost Ebola virus vaccine regimen in healthy adults in the UK and Senegal[J]. J Infect Dis, 219, 1187-1197. doi: 10.1093/infdis/jiy639
-
Ward BM, 2005: Visualization and characterization of the intracellular movement of vaccinia virus intracellular mature virions[J]. J Virol, 79, 4755-4763. doi: 10.1128/JVI.79.8.4755-4763.2005
-
Webster DP, Dunachie S, Vuola JM, Berthoud T, Keating S, Laidlaw SM, McConkey SJ, Poulton I, Andrews L, Andersen RF, Bejon P, Butcher G, Sinden R, Skinner MA, Gilbert SC, Hill AVS, 2005: Enhanced T cell-mediated protection against malaria in human challenges by using the recombinant poxviruses FP9 and modified vaccinia virus Ankara[J]. Proc Natl Acad Sci USA, 102, 4836-4841. doi: 10.1073/pnas.0406381102
-
Wiebe MS, Traktman P, 2007: Poxviral B1 kinase overcomes barrier to autointegration factor, a host defense against virus replication[J]. Cell Host Microbe, 1, 187-197. doi: 10.1016/j.chom.2007.03.007
-
Wyatt LS, Earl PL, Eller LA, Moss B, 2004: Highly attenuated smallpox vaccine protects mice with and without immune deficiencies against pathogenic vaccinia virus challenge[J]. Proc Natl Acad Sci USA, 101, 4590-4595. doi: 10.1073/pnas.0401165101
-
Yeh WW, Moss B, Wolffe EJ, 2000: The vaccinia virus A9L gene encodes a membrane protein required for an early step in virion morphogenesis[J]. J Virol, 74, 9701-9711. doi: 10.1128/JVI.74.20.9701-9711.2000
-
Yuen L, Moss B, 1987: Oligonucleotide sequence signaling transcriptional termination of vaccinia virus early genes[J]. Proc Natl Acad Sci USA, 84, 6417-6421. doi: 10.1073/pnas.84.18.6417